A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Novartis, Takeda to enter next Medicare drug price negotiations
Novartis, Takeda to enter next Medicare drug price negotiations
US International Trade Commission to take a closer look at Chinese biotech
US International Trade Commission to take a closer look at Chinese biotech
Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina
Merck cuts more than 150 jobs at new Gardasil vaccine plant in North Carolina
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
CHMP recommends Moderna's flu-Covid shot and Novartis pill for hives
Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design
Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design
Ginkgo divests biosecurity arm; J&J's early prostate cancer data
Ginkgo divests biosecurity arm; J&J's early prostate cancer data
Padcev-Keytruda combo delivers more positive data in bladder cancer
Padcev-Keytruda combo delivers more positive data in bladder cancer
Novartis closes Avidity deal as rare heart disease spinout launches
Novartis closes Avidity deal as rare heart disease spinout launches
Investors are pumping money into AI tools for health insurers
Investors are pumping money into AI tools for health insurers
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case
DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case
Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart
Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart
FDA probes internal Prasad complaints with outside help
FDA probes internal Prasad complaints with outside help
Boehringer wins accelerated approval for first-line use of lung cancer drug
Boehringer wins accelerated approval for first-line use of lung cancer drug
Senate hearing raises FDA-related concerns for new rare disease drugs
Senate hearing raises FDA-related concerns for new rare disease drugs
Viatris plans to lay off up to 10% of staff, discloses Indian factory fire
Viatris plans to lay off up to 10% of staff, discloses Indian factory fire
Why did my doctor push Grail’s dubious cancer test?
Why did my doctor push Grail’s dubious cancer test?
AtaiBeckley stock drops on Phase 2a data; Disc to refile rare disease drug
AtaiBeckley stock drops on Phase 2a data; Disc to refile rare disease drug
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page